Effects of SGLT2 inhibitor on tumor‐releasing chemokines/cytokines in Hep3B and Huh7 cells

Documenti analoghi

• Gene cloning and expression analysis of Gro/KC by primary hepatocytes
  di: GH. Hassanshahi, et al.
  Pubblicazione: (2007-01-01)
• Drug Transporter Expression and Activity in Human Hepatoma HuH-7 Cells
  di: Elodie Jouan, et al.
  Pubblicazione: (2016-12-01)
• Metabolic dysfunction-associated fatty liver disease is a ubiquitous latent cofactor in viral- and alcoholic-related hepatocellular carcinoma: Editorial on “Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis”
  di: Toru Nakamura, et al.
  Pubblicazione: (2024-10-01)
• Chemokines, chemokine receptors and disease : current topics in membranes /
  di: Schwiebert, Lisa M.
  Pubblicazione: (2005)
• A rapid increase in lysophospholipids after geranylgeranoic acid treatment in human hepatoma-derived HuH-7 cells revealed by metabolomics analysis
  di: Yoshihiro Shidoji, et al.
  Pubblicazione: (2021-12-01)